Forest Sees No Significant Impact From Antidepressant "Black Box" Warnings

The antidepressant relabeling will only have a "mild" effect on a small part of the business, Forest says. Some of the impact could be offset if competitors scale back on direct-to-consumer advertisements: Pfizer is still running Zoloft TV ads in the days following FDA's decision to require new warnings.